Browsing Tag

LowerRisk

Jasper Therapeutics Announces First Patient Dosed in a Phase 1 Trial of Briquilimab in Lower-Risk…

Jason Junior Jun 22, 2023

REDWOOD CITY, Calif., June 22, 2023 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on the development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address…

Health

Jasper Therapeutics Announces Development Prioritization of Briquilimab in Chronic Diseases,…

Jason Junior Jan 10, 2023

REDWOOD CITY, Calif., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper” or the “Company”), a biotechnology company developing novel antibody therapies and stem cell transplant conditioning agents…

Business

US doctors reconsider Pfizer’s Paxlovid for lower-risk Covid patients

Kemal Pasha May 29, 2022

Use of Pfizer Inc's COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients after a U.S.public health agency…

Business

U.S. doctors reconsider Pfizer’s Paxlovid for lower-risk COVID patients

Kemal Pasha May 28, 2022

Breadcrumb Trail Links PMN Business Author of the article: Article content Use of Pfizer Inc’s COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients after a…